Pharmapedia Pro
Medicines/Generics/Hexobarbitone (Na)

Hexobarbitone (Na)

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Hexobarbitone (Na) is a barbiturate derivative having hypnotic and sedative effects. It was used in the 1940s and 1950s as an agent for inducing anesthesia for surgery, as well as a rapid-acting, short-lasting hypnotic for general use, and has a relatively fast onset of effects and short duration of action.
Indications
Hexobarbitone (Na) is primarily indicated in conditions like Insomnia.
Contraindications
Hexobarbitone (Na) is contraindicated in conditions like Anemia, Septicemia, Cancer, Liver diseases, Ileus hyperemesis.
Side Effects
The severe or irreversible adverse effects of Hexobarbitone (Na), which give rise to further complications include Grand-mal seizures, Abstinence syndrome. Hexobarbitone (Na) produces potentially life-threatening effects which include Bronchospasm, Fall in B.P, Laryngospasm, Respiratory difficulties, Coughing, Tissue damage, which are responsible for the discontinuation of Hexobarbitone (Na) therapy. The signs and symptoms that are produced after the acute overdosage of Hexobarbitone (Na) include Hypotension, Death, Respiratory depression, Renal failure, Poisoning, Peripheral vascular collapse, Feeble heart beat, Lowered body temperature. The symptomatic adverse reactions produced by Hexobarbitone (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Ataxia, Lethargy, Sedation, Slurred speech, Allergic skin reactions, Hangover, Nystagmus, CNS depression, Ataxia.
Warnings
No warnings information is recorded for this medicine yet.
High Risk Groups
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
3.571 to 7.142 mg/kg (5.4 (5.3565)) As recommended. IV — Once or As Required
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Hexobarbitone (Na) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholRifampicinSomatostatinSomatostatin has been demonstrated to prolong or enhance the effects of Hexobarbitone (Na). These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Storage
No storage information is recorded for this medicine yet.

Available Brands in Pakistan

No brands are recorded for this generic.